Pharmaceutical Manufacturing - Detecting Diethylene Glycol Adulteration in Glycerol using FT-IR
View as a Web Page
News Medical
 
  Pharmaceutical Manufacturing Pharmaceutical Manufacturing logo  
  The latest pharmaceutical manufacturing news from News Medical  
 

Enhanced compliance with ERWEKA DT 950 on-device Audit TrailEnhanced compliance with ERWEKA DT 950 on-device Audit Trail

Discover the ERWEKA DT 950 Dissolution Tester with a fully integrated on-device Audit Trail securing FDA regulated 21 CFR Part 11 compliance. It ensures secure electronic records, data integrity, and transparent workflows without external software. Designed for GMP and R&D labs, it enables efficient, reliable, and fully documented dissolution testing.

Explore Compliance Features
 
 
    Detecting Diethylene Glycol Adulteration in Glycerol using FT-IRDetecting Diethylene Glycol Adulteration in Glycerol using FT-IR
 
This application note demonstrates detection of diethylene glycol (DEG) adulteration in glycerol at the FDA safety limit of 0.1 %. Unlike chromatographic methods requiring extensive preparation, mid infrared spectroscopy with Adulterant Screen™ provides rapid, solvent free identification and semi quantitative estimation of DEG.
Read the App Note
 
 
   The Long Road to Getting Nanomedicine in the ClinicThe Long Road to Getting Nanomedicine in the Clinic
 
Nanomedicine offers targeted drug delivery, but biological, safety, manufacturing, and regulatory barriers continue to slow clinical translation.
 
 New Membrane Technology Hub is Tackling Cancer Drugs, Carbon Capture and the Global Water Crisis
 
New Membrane Technology Hub is Tackling Cancer Drugs, Carbon Capture and the Global Water CrisisA new European research network is accelerating innovations in membrane science that could cut the cost of life-saving cancer treatments, pull CO2 directly from industrial emissions, and deliver clean water to millions — all with technologies thinner than a human hair.
 
 
 Gene Editing Reprograms Immune System to Produce Therapeutic Proteins
 
Gene Editing Reprograms Immune System to Produce Therapeutic ProteinsAn innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins-including certain kinds of highly potent antibodies the are naturally difficult to produce-by reprogramming the immune system itself.
 
 
 Building quality into drug development for safer, faster medicines
 
Building quality into drug development for safer, faster medicinesDiscover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
 
 
 What are the latest advances in RSV vaccine research and why do they matter?
 
What are the latest advances in RSV vaccine research and why do they matter?Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.
 
 
 Biologics drug development: Key considerations
 
Biologics drug development: Key considerationsExplore key considerations for biologics drug manufacturing, from early development to scalable production and consistent product quality.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026